Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

medical developments md&p limited - methoxyflurane - inhalation vapour, liquid - 99.9 %, 3 millilitre(s) - methoxyflurane

Saudi - Kiingereza - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

medical developments international limited, australia - methoxyflurane - inhalation vapour, liquid - 99.9 %

Saudi - Kiingereza - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

medical developments international limited, australia - methoxyflurane - inhalation vapour, liquid - 99.9 %

Saudi - Kiingereza - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

medical developments international limited, australia - methoxyflurane - inhalation vapour, liquid - 99.9 %

Saudi - Kiingereza - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

medical developments international limited, australia - methoxyflurane - inhalation vapour, liquid - 99.9 %

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

medical developments international limited - methoxyflurane, quantity: 999 mg/g - inhalation - excipient ingredients: butylated hydroxytoluene - indications for product supplied in canada - short term relief of moderate to severe acute pain, associated with trauma or interventional medical procedures, in conscious adult patients. indications for product supplied in guatemala - for emergency relief of pain by self administration in conscious haemodynamically stable patients with trauma and associated pain, under supervision by personnel trained in its use. indications for product supplied in south africa: 1. for emergency relief of pain by self administration in conscious haemodynamically stable patients with trauma and associated pain, under supervision of healthcare professionals trained in its use. 2. for the relief of pain in monitored conscious patients who require analgesia for surgical procedures such as the change of dressings. indications for the product supplied in taiwan: 1. for emergency relief of pain by self administration in conscious haemodynamically stable patients with trauma and associated pain, under supervision of personnel trained in its use (see dosage and administration). 2. for the relief of pain in monitored conscious patients who require analgesia for surgical procedures such as the change of dressings (see dosage and administration). indications for product supplied in united arab emirates: 1. for emergency relief of pain by self administration in conscious haemodynamically stable patients with trauma and associated pain, under supervision of healthcare professionals trained in its use. 2. for the relief of pain in monitored conscious patients who require analgesia for surgical procedures indication for product supplied in austria, belgium, croatia, cyprus, czech republic, denmark, finland, france, germany, iceland, ireland, norway, poland, portugal, romania, slovakia, slovenia, spain, sweden, switzerland, united kingdom: short term relief of moderate to severe acute pain, associated with trauma or interventional medical procedures, in conscious adult patients. indication for product supplied in hong kong: 1) for emergency relief of pain by self administration in conscious haemodynamically stable patients with trauma and associated pain, under supervision of personnel trained in its use; 2) for the relief of pain in monitored conscious patients who require analgesia for surgical procedures. indication for product supplied in saudi arabia: emergency relief of moderate to severe pain in conscious adult patients with trauma and associated pain.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

medical developments international limited -

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

medical developments international limited -

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

medical developments international limited -

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

medical developments international limited -